Active substance expiry date postponed whilst the renewal evaluation is completed in the EU For reasons beyond the control of the applicant, the approval of the active substance/product type combination listed below was likely to expire before a decision could be taken on its renewal under the EU BPR. To allow sufficient time for the renewal evaluation to be completed, a decision has been taken to postpone the expiry of the approval until the following date. This affects NI: If you want to supply new biocidal products containing this active substance, you can still apply for EU BPR product authorisation. New products (including new trade names) must not be supplied in NI until product authorisation is granted. HSE will provide a separate update on the renewal decision when relevant. Apply for product authorisation by the deadlines to keep your products on the NI market Approval dates for the following EU BPR active substances are coming up: - Formaldehyde (CAS 50-00-0 EC 200-001-8) in product types 2 and 3
1 February 2022
- sec-butyl 2-(2-hydroxyethyl)piperidine-1- carboxylate/Icaridine (Icaridine) (CAS 119515-38-7 EC 423-210-8) in product type 19
1 February 2022
- Alkyl (C12-16) dimethylbenzyl ammonium chloride (CAS 68424-85-1 EC 270-325-2) in product types 3 and 4
1 November 2022
- N,N-Didecyl-N,N-dimethylammonium chloride (Didecyldimethylammonium chloride) (CAS 7173-51-5 EC 230-525-2) in product types 3 and 4
1 November 2022 If you supply biocidal products containing these active substances in the relevant product types, don't forget to apply for EU BPR product authorisation by the date above to keep them on the NI market. Make sure you are receiving important information about your product authorisations and approvals If you hold product authorisations and approvals in NI under the EU BPR or the Control of Pesticides Regulations (COPR), you should make sure HSE has the right contact details for you. If the details we hold are out of date, you may not receive important information about your product authorisation or approval. Update your details. |
No comments:
Post a Comment